Article: GTCR Golder Rauner Announces Agreement to Sell CuraScript for $335 Million.

Business Editors

CHICAGO--(BUSINESS WIRE)--Dec. 22, 2003

GTCR Golder Rauner (GTCR), one of the nation's leading private equity firms, today announced it has entered into a definitive agreement to sell CuraScript Pharmacy, Inc. and CuraScript PBM Services, Inc. (collectively, CuraScript) to Express Scripts, Inc. (Nasdaq: ESRX) for approximately $335 million in cash. The transaction, which is expected to close early in 2004, is subject to customary closing conditions and regulatory approvals. JP Morgan served as financial advisor to CuraScript; Kirkland & Ellis provided legal counsel.

CuraScript, the nation's largest privately held specialty ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!